Context Capital Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Context Capital Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19,935	Closed	-$20K	–	707
2021 Q4	$20K	Sell	19,935 -7,231	-27%	-$14.2K	﹤0.01%	525
2021 Q3	$58K	Hold	27,166	–	–	0.01%	404
2021 Q2	$125K	Sell	27,166 -13,885	-34%	-$59.4K	0.01%	404
2021 Q1	$213K	Sell	41,051 -25,465	-38%	-$142K	0.02%	347
2020 Q4	$182K	Buy	+66,516	New	+$167K	0.02%	205

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

Context Capital Management's WGSWW Position: Q1 2022 in Review

Context Capital Management sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2022, closing a stake of 19,935 shares — an estimated $20K sold.

Context Capital Management first reported a position in WGSWW in Q4 2020 and held it in 5 quarters. The position peaked at $213K in Q1 2021. 27 funds tracked by Wall St. Rank hold WGSWW as of Q1 2022.

Context Capital Management reported no remaining GeneDx Holdings Warrant position as of Q1 2022 after selling out during the quarter.
Context Capital Management sold 19,935 GeneDx Holdings Warrant shares in Q1 2022, an estimated $20K.
Context Capital Management first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 5 quarters.
Context Capital Management's GeneDx Holdings Warrant position peaked at $213K in Q1 2021.
27 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2022.

Based on Context Capital Management's 13F filing for Q1 2022, filed 9 May 2022.